Adagio Medical Holdings, Inc. · NASDAQ (us_market)
Healthcare · Medical Devices · United States
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-10-28$1.27 RISE2026-03-10$0.96 PEAK2026-04-14$1.63 168d | -24.4% 133d | Missed | Missed | — | — | +69.8% 35d | Missed |
DROP2025-10-07$2.36 RISE2026-01-20$0.87 PEAK2026-04-14$1.63 189d | -63.1% 105d | Missed | Missed | — | — | +87.1% 84d | Missed |
DROP2025-10-07$2.36 RISE2025-11-17$0.77 PEAK2025-12-17$1.21 71d | -67.4% 41d | Missed | Missed | — | — | +57.1% 30d | Missed |
DROP2025-04-17$1.78 RISE2025-08-21$1.23 PEAK2025-10-07$2.36 173d | -31.2% 126d | Missed | Missed | — | — | +92.7% 47d | Missed |
DROP2025-04-17$1.78 RISE2025-06-18$1.08 PEAK2025-07-23$1.77 97d | -39.3% 62d | Missed | Missed | — | — | +63.9% 35d | Missed |
DROP2024-11-29$2.67 RISE2025-04-04$0.74 PEAK2025-04-17$1.78 139d | -72.2% 126d | Missed | Missed | — | — | +140.2% 13d | Missed |
DROP2024-09-17$4.44 RISE2025-01-21$0.75 PEAK2025-02-26$1.56 162d | -83.1% 126d | Missed | Missed | — | — | +107.7% 36d | Missed |
DROP2024-08-01$9.05 RISE2024-10-03$2.52 PEAK2024-11-14$3.71 105d | -72.2% 63d | Missed | Missed | — | — | +47.2% 42d | Missed |
No scored news yet for a sentiment trend.
PMA Submission Supported by FULCRUM-VT Pivotal Trial Data — 209 Patients Across 20 Leading Centers; Breakthrough Device Designation Previously GrantedMarks the First-Ever PMA Submission for a Purpose-Built VT Ablation
May 2026 B of A Securities 1 2026 Health Care Conference Leadership Team Over 200 Combined Years of Med...
LAGUNA HILLS, Calif., May 12, 2026--Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the first quarter ended March 31, 2026.
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 39.22 percent increase over losses of $(0.51) per
LAGUNA HILLS, Calif., April 29, 2026--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 4:35pm PDT in Las Vegas.
FULCRUM-VT Investor Event Dr. Atul Verma • Dr. William Stevenson • Dr. Matthew Hakimi April 27, 2026 EFFECTIVENESS AND SAFETY OF...
Adagio Medical shares rise after vCLAS trial shows strong VT outcomes, reduced drug use, and lower readmissions ahead of FDA review.
LAGUNA HILLS, Calif., April 26, 2026--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results from its FULCRUM-VT Investigational Device Exemption ("IDE") clinical trial, which will be used to support the Company’s application for Food and Drug Administration ("FDA") Premarket Approval of the vCLAS Ventricular Ablation System. The results were present
Adagio Medical Holdings Inc: Adagio Medical announces positive pivotal results for vCLAS® ventricular ablation system Adagio Medical - 84% freedom from shock and 59% freedom from VT recurrence...
LAGUNA HILLS - Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, announced that its Ultra-low Temperature Ablation...
LAGUNA HILLS, Calif., April 16, 2026--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that its Ultra-low Temperature Ablation technologies (ULTA) for the treatment of scar-related ventricular tachycardia will be featured in several presentations at the Heart Rhythm Society's 47th Annual Scientific Sessions – Heart Rhythm 2026 conference, to be held from Thursd
Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Energy. See their ratings and targets here.
Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrades/ initiations on analyst ratings page.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ADGM | -29.71% | -30.38% | -30.38% | -35.93% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -32.68% | -24.67% | -26.94% | -48.62% |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-05-12 | -0.29 | -0.31 | -6.90% |
| 2026-03-27 | -0.31 | -0.16 | +48.39% |